Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine for Congenital Adrenal Hyperplasia
NCT00000102Phase 2Completed
- Sponsor
- National Center for Research Resources
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in congenital adrenal hyperplasia (CAH) comparing Nifedipine with Placebo (2 arms). Primary endpoint: Adrenocorticotropic Hormone Levels. Status: completed.
02
Drugs
nifedipine
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT00000102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000102.